Reeve Emma — SEC Form 4 filings
SEC reporting owner CIK 1680329. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-16 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 7 filings — 75,733 shares, $5,163,979 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: sale of 12,000 shares @ $69.50 ($834,000) in PTC THERAPEUTICS, INC., filed 2025-10-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. (PTCT) | Director | 9 | — | 19 legs · 75,733 sh · $5,163,979 | 26 |
| Whitehawk Therapeutics, Inc. (WHWK) | Director | 3 | — | — | 3 |
| Editas Medicine, Inc. (EDIT) | Director | 1 | — | — | 1 |
Form 4 filings — Reeve Emma
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/award (A): 38,040 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Option exercise (M): 734 @ $46.54 · Sale (S): 734 @ $76 · Grant/award (A): 3,475 (derivative) @ $0 · Option exercise (M): 734 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 733 @ $46.54 · Sale (S): 733 @ $78.62 · Option exercise (M): 733 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 10,000 @ $51.16 · Sale (S): 10,000 @ $79.50 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 7,333 @ $46.54 · Sale (S): 7,333 @ $74.50 · Option exercise (M): 7,333 (derivative) @ $0 | EDGAR |
| 2025-10-31 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 3,666 @ $69.50 · Option exercise (M): 12,000 @ $38.10 · Sale (S): 12,000 @ $69.50 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 10,000 @ $39.42 · Sale (S): 3,028 @ $65.09 · Sale (S): 4,591 @ $66.09 · Sale (S): 2,381 @ $66.87 · Option exercise (M): 6,912 @ $33.02 · Sale (S): 2,163 @ $65.02 · +9 more | EDGAR |
| 2025-09-16 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 3,534 @ $59.50 · Sale (S): 1,334 @ $59.50 · Option exercise (M): 10,000 @ $25.69 · Sale (S): 10,000 @ $59.50 · Option exercise (M): 837 @ $33.63 · Sale (S): 837 @ $59.50 · +2 more | EDGAR |
| 2025-06-16 | 4 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/award (A): 40,006 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 8,800 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Aadi Bioscience, Inc. (AADI) | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1680329 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →